WHO WE ARE
We share a passion for helping our clients grow
For over 30 years, Kx Advisors (operating as the healthcare practice of Kaiser Associates) have provided advisory services to help leading pharmaceutical, biotechnology and medical technology companies fully capitalize on product opportunities, navigate the environment with greater certainty, and maximize the lifetime commercial value of their portfolios.
We do this by conducting comprehensive primary research and data-driven analysis at all stages of the product lifecycle to inform the decision making of sales, marketing and strategy executives. The Kx
approach establishes the required fact base to vet critical decisions and brings together data from disparate sources to develop holistic strategies.
With offices in Washington D.C, London, and Hong Kong, Kx Advisors possesses the unique ability to generate global insights from physicians, thought leaders, patients, competitors, partners, regulators, suppliers, and payers.
The Kx approach establishes the required fact base to vet critical decisions and brings together data from disparate sources to develop holistic strategies.
How we’re different
We focus on growth strategy
Unlike large consulting firms who toggle between operational work and heterogenous strategy work, we live and breathe healthcare growth strategy. As a result, we have developed deep expertise in exploring new business models, evaluating new technologies, entering new markets, and capitalizing on new policies. Our focus drives results.
We prioritize pragmatism and clarity
We pride ourselves on developing elegant solutions to complex problems. We share a passion for helping our clients devise winning strategies and gain organization buy-in through clear business cases, impactful storytelling, and actionable recommendations.
We believe in data-driven decision making
Insight generation and quantitative rigor define our consulting approach. We are experts at designing research to inform quantitative models, developing forecasts in emerging and innovative markets, and quantifying what is difficult to quantify.
We deliver a first-class client experience
We value collaboration and partnership above all else and design our engagements to follow a highly iterative process. We start fast, deliver against compressed timelines and respond to changing client needs with agility. Our senior leaders remain actively involved throughout our engagements and set a high standard of excellence.
Dan O’NeillSenior Vice President
Dan O’Neill is a Senior Vice President and co-leads Kx Advisors. He is based in Washington, DC.
Dan has significant experience developing commercial growth strategies for leading Pharmaceutical, Medical Device and Health Technology clients. Since joining Kaiser Associates in 2006, Dan has developed expertise across all major therapeutic areas and project types. Specific emphases include commercial due diligence, strategic marketing, product launch planning, market opportunity assessments, and competitive strategy. He has expertise in integrated research and quantitative modeling techniques related to product pricing and forecasting.
Dan started his career in finance and banking where he developed his quantitative background. Dan holds an MBA from the McDonough School of Business at Georgetown University and a BBA from the University of Kentucky.
Bob SerranoSenior Vice President
Bob Serrano is a Senior Vice President and co-leads Kx Advisors. He is based in Washington, DC.
Bob has nearly 20 years of experience in the healthcare industry, specializing in specialty pharma, interventional medicine, and clinical diagnostics. Bob has extensive expertise in building growth strategies across therapeutic areas including oncology, dermatology, neurology, immunology, and cardiology. Prior to Kaiser Associates and Kx Advisors, Bob held several strategy and sales roles at Abbott (now AbbVie), and led North American laboratory marketing for QIAGEN’s molecular diagnostics business.
Bob earned an MBA from the Kellogg School of Management at Northwestern University, and a Master’s in Health Administration and a BS in Nutritional Science from Cornell University.
Jenna RiffellVice President
Jenna Riffell is a Vice President at Kx Advisors, based in London, UK.
Jenna has advised Fortune 500 pharmaceutical and biotech companies on growth strategy across the value chain. She specializes in pharma/biotech, health IT, and medical devices, with particular expertise in dermatology, ophthalmology, rare diseases, and oncology. Her work includes portfolio strategy, geographic expansion strategy, commercial due diligence, strategic marketing, and launch planning.
Jenna holds a PhD in Biochemistry and Molecular Biology and a BSCh, Combined Honors in Chemistry and Biochemistry, from the University of British Columbia. She also completed a postdoctoral fellowship at the Institute of Cancer Research in London, before moving into consulting via boutique life science consultancies prior to joining Kaiser in 2015.
Sean Vander LindeVice President
Sean Vander Linde is a Vice President at Kx Advisors and is based in Washington, DC.
Sean brings deep experience leading engagements across the healthcare value chain with provider, health IT, biopharma, and medical device companies. His expertise includes advising clients on corporate strategy, market opportunity assessments, new product launch, and commercial due diligence. Prior to joining Kaiser Associates and Kx Advisors, he worked at L.E.K. Consulting and PwC focusing on healthcare.
Sean holds an MBA from the Tuck School of Business at Dartmouth and a BA in Political Science from the University of North Carolina at Chapel Hill.
Our global reach
Kx Washington, D.C.1615 L Street, NW, 13th Floor
Washington, DC 20036
Kx London91 Wimpole Street
London W1G 0EF, UK
Kx Hong KongSuite 901, Level 9, The Hong Kong Club Building
3A Chater Road, Central, Hong Kong